Executive Officer at SME

Moon Kil Woong is currently a VP at a SME. Previously he was a tech stock consultant, VP of Research at ING, and sell side Director at Crédit Agricole Indosuez. Moon Kil Woong has a Masters in Public Administration from SJSU.

He contributes to both TalkMarkets and Seeking ... more

ALL CONTRIBUTIONS

E Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
The corporate culture of CytoDyn Inc. has created an atmosphere where management is now able to realize the full potential of a drug that was essentially tossed in the garbage heap.
Read
E CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
Cytodyn investors are not reacting positively to good news despite being extremely positive.
Read
E CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
This is to clarify the recent conference call and counter misleading information on it by shorters etc.
Read
E GRIL For Americans Demanding Healthier Fast Food Options: The Evolving Restaurant Landscape Amid The COVID-19 Pandemic
Food behaviors are changing. GRIL is expanding to adapt.
Read
E There Is Beta In Protalix Stock Due To PRX-102
Protalix offers positive Beta on PRX-102 success.
Read
E CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Cytodyn, is set to move on positive information and this article gives updated information on why it may move in the near term and an update on their Covid drug trial.
Read

Comments

Latest Comments
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
3 days ago

Thanks. I am hoping for more good news. Given the stock has support even on low volume higher volume should really see a good bump.

In this article: CYDY
COVID Vaccines And The Stock Market
3 days ago

Yes the elderly are being hit the worst and there seems to be little care about them in Washington. Sadly they aren't the hot demographic politicians are after.

Bitcoin BTC Technical Analysis - Elliott Wave
4 days ago

New coin issues have dried up slowing the depreciation of all crypto save Bitcoin and inflation has risen. I think this is the biggest drivers, not the expectation governments will issue more coin, which will be adverse to other cryptos for the same reason the 100s of crypto currencies already issued supressed bitcoins rise for quite a while. Likewise, it seems pretty clear no one ever intends to use cryptos for much else than hording, speculation, and shuffling money around. The fact that banks are going to create a regulatory infrastructure that will potentially not make them much more free than cash. That is also negative.

Anyways we will see what will happen especially when more is no longer being made and they figure out who's going to pay the massive electric bill for transaction costs. There is not a well though out plan for this transition.

In this video: BITCOMP
COVID Vaccines And The Stock Market
7 days ago

What we need to do is work with and advance research in treating those that catch the disease or currently have it. They seem to be a lost voice in all this. This may be a case where treatment beats a "cure" much like the flu. We need to prevent it from being fatal and address the people suffering from heart issues, strokes, etc. from Covid who are often not counted or treated correctly by our system. Covid has killed more people than we currently acknowledge.

COVID Vaccines And The Stock Market
8 days ago

That's because taking more than 2 doses of a vaccine makes it ineffective for taking it for a few years. I would like to see science and proof of its effectiveness and longevity. The push to rush it makes many like me more doubtful of what they claim.

COVID Vaccines And The Stock Market
9 days ago

It is doubtful they will eradicate the virus, especially since they are designed to prevent the infection from spreading an a person not killing the virus and none are close to 100% effective. As I know, there are no studies to say if any of the vaccines prevent transmission if one with the vaccine gets Covid. I figure that whatever vaccine is used will lead to mutations and be ineffective rapidly.

Opening Up The Economy, Case By Case
9 days ago

Sadly with the case counts rising to new levels and the government doing nothing until a new administration besides trying to start a war in Iran it will be a while.

Terrible Thursday
9 days ago

Countries can do about anything as long as their government says they can. Doing it safely for its citizens is another question.

Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
9 days ago

Indeed if you need safety you should not invest in small biotechs. That said, both of these stocks have their own risks as does the vaccine hype. They got taxpayer money for their Covid efforts, however, we will see if they are fruitful in this or just got subsidized. That said, this has already past. Getting in now is even more risky. There are sure to be a lot more bumps along the way and the rush to get a vaccine out early is not just a bad idea from a regulatory standpoint, but it is a health and legal issue.

The last statement as many people have said, is that this is something that should be taken care of with improved treatments so it is not life threatening and thus a vaccine won't be necessary. If we get to that point the need will vanish, especially since none of them are claiming 100% efficacy and the virus hasn't mutated that much yet. It may drop considerably after it is used.

In this article: CYDY
Terrible Thursday
12 days ago

Safe doesn't mean effective and given the safety hasn't studied long term effects and the results aren't completed, out, or published fast track means very little besides potentially doctors can prescribe it to you. As stated, it means very little and is on par with the Russian vaccine in terms of lack of disclosure or effectiveness. Vaccines need months of trials with large study groups to prove effectiveness and efficacy factoring out other things that can bias the findings and factoring in all demographic considerations. In addition, you need to track effectiveness over time and safety.

Releasing something because no one taking it has gotten Covid versus a few in the general group means very little and does little to prove its effectiveness. I wouldn't hold my horses over this.

1 to 10 of 2307 comments
1 2 3 ... 231

STOCKS I FOLLOW

GOOG Alphabet Inc. (Google)
SKM SK Telecom Co. Ltd.

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

San Jose State University
MPA
Public Administration

Publications